ClinicalTrials.gg
CompletedNCT05371717Updated Oct 23, 2024

Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite

An interventional study of Domiciliary use of Biorepair Total Protection + Biorepair Shock Treatment and Biorepair Total Protection in Gastro Esophageal Reflux and Dental Erosion, sponsored by University of Pavia. Completed at 1 site in Italy. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-10-23.

Sponsored by University of Pavia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of the present study is to evaluate dental erosion in patients with gastroesophageal reflux disease (GERD).

Patients consenting to participate to the study will undergo periodontal evaluation at the baseline. Then, professional dental hygiene will be performed. Patients will be randomly assigned to:

  • Trial group: home oral hygiene with Biorepair Total Protection + Biorepair Shock Treatment twice a day
  • Control group: home oral hygiene with Biorepair Total Protection Patients will be evaluated after 1, 3, 6, 9 and 12 months from baseline.
Read the detailed description

The aim of the present study is to evaluate dental erosion in patients with gastroesophageal reflux disease (GERD).

Patients consenting to participate to the study will undergo periodontal evaluation at the baseline. Then, professional dental hygiene will be performed. Patients will be randomly assigned to:

  • Trial group: home oral hygiene with Biorepair Total Protection + Biorepair Shock Treatment twice a day
  • Control group: home oral hygiene with Biorepair Total Protection Patients will be evaluated after 1, 3, 6, 9 and 12 months from baseline.
02

Conditions studied

  • Gastro Esophageal Reflux
  • Dental Erosion

Keywords

  • biomimetic hydroxyapatite
  • remineralization
03

In context

Gastroesophageal Reflux

1,211 studies on the registry are indexed under Gastroesophageal Reflux; 202 are open to participants now.

This study's enrollment of 30 is below the median of 68 across 796 interventional studies indexed under Gastroesophageal Reflux.

Browse Gastroesophageal Reflux studies →

Lead sponsor

University of Pavia is the lead sponsor of 144 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients with dental erosion
  • no proton pumps before pH examination

Exclusion criteria

Exclusion Criteria:

  • no dental erosion
  • neurological and psychiatric diseases;
  • pregnant and/or breastfeeding women;
  • patients with poor compliance.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Trial Group

    Domiciliary use of Biorepair Total Protection + Biorepair Shock Treatment application

    Other: Domiciliary use of Biorepair Total Protection + Biorepair Shock Treatment

  • Active comparator
    Control group

    Domiciliary use of Biorepair Total Protection

    Other: Biorepair Total Protection

Interventions

  • OtherDomiciliary use of Biorepair Total Protection + Biorepair Shock Treatment

    Domiciliary use of Biorepair Total Protection twice a day for oral hygiene + Biorepair Shock Treatment application for 10 min once a day.

  • OtherBiorepair Total Protection

    Domiciliary use of Biorepair Total Protection twice a day for oral hygiene + Biorepair Shock Treatment application for 10 min once a day.

06

What researchers measure

Primary outcomes

  1. Change of BEWE (Basic Erosive Wear Examination)

    Scoring criteria (Barlet et al., 2008): * 0: no erosive tooth wear; * 1: initial loss of surface texture; * 2: distinct defect, hard tissue loss \< 50% of the surface area; * 3: hard tissue loss ≥ 50% of the surface area. IntactTooth smartphone application will be used to calculate this index.

    Time frame: Study begin, 1, 3, 6, 9 and 12 months after the baseline

  2. Change in Schiff Air Index - Dental sensitivity test

    Scoring criteria: 0: the subject did not respond to air blasting; 1. the subject responded to air blasting; 2. the subject responded to air blasting and requested discontinuation; 3. the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.

    Time frame: Study begin, 1, 3, 6, 9 and 12 months after the baseline

  3. Change in Plaque Index (PI% - O' Leary Index)

    Evaluation of the presence of plaque on the 4 surfaces of teeth on the total amount of dental surfaces. Formula = n ° sites with plaque / total n ° of dental surfaces x100

    Time frame: Study begin, 1, 3, 6, 9 and 12 months after the baseline

  4. Change in Bleeding Score (BS - Mombelli et al.)

    Scoring criteria: 0: no bleeding 1. isolated visible spots 2. blood forms a confluent red line on the mucosal margin 3. profuse and copious bleeding

    Time frame: Study begin, 1, 3, 6, 9 and 12 months after the baseline

  5. Laryngopharyngeal pH monitoring

    Data was collected wirelessly for 24 hours and then analysed. Length, severity and number of reflux episodes were calculated. The RYAN score was used to evaluate for laryngopharyngeal acid reflux and was calculated for both the upright and supine positions. A RYAN score \>9.4 in the upright position or \>6.8 in the supine position was considered positive. Patients with a positive RYAN score in either the upright or supine positions were considered positive for laryngopharyngeal acid reflux.

    Time frame: Study begin, 1, 3, 6, 9 and 12 months after the baseline

  6. Erosion risk level

    For each sextant, the highest BEWE value will be chosen. A mean of all the sextant values will be performed to calculate erosion risk level. IntactTooth smartphone application will be used to calculate this index.

    Time frame: Study begin, 1, 3, 6, 9 and 12 months after the baseline

07

Study locations

1 site
  • Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
    Pavia, Lombardy 27100, Italy
08

References and documents

Individual participant data

Plan to share: No — Data will be available upon motivated request to the Principal Investigator.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05371717
Responsible party
Andrea Scribante (Associate Professor, Principal Investigator, University of Pavia) — Principal investigator
First posted
May 12, 2022
Start date
May 1, 2022
Primary completion
Sep 17, 2024
Completion
Sep 20, 2024
Last update
Oct 23, 2024

Study contacts

Andrea Scribante, DDS, PhD, MS
principal investigator · University of Pavia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion